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Visible-range circular dichroism titrations were used to study Cu(II) binding properties of Multimetal Binding Site (MBS) of
Human Serum Albumin (HSA). The formation of ternary MBS-Cu(II)-Buﬀer complexes at pH 7.4 was positively veriﬁed for
sodium phosphate, Tris, and Hepes, the three most common biochemical buﬀers. The phosphate > Hepes > Tris order of aﬃnities,
together with strong spectral changes induced speciﬁcally by Tris, indicates the presence of both Buﬀer-Cu(II) and Buﬀer-HSA
interactions. All complexes are strong enough to yield a nearly 100% ternary complex formation in 0.5mM HSA dissolved in
100mM solutions of respective buﬀers. The eﬀects of warfarin and ibuprofen, speciﬁc ligands of hydrophobic pockets I and II in
HSA on the Cu(II) binding to MBS were also investigated. The eﬀects of ibuprofen were negligible, but warfarin diminished the
MBS aﬃnity for Cu(II) by a factor of 20, as a result of indirect conformational eﬀects. These results indicate that metal binding
properties of MBS can be modulated directly and indirectly by small molecules.
1.Introduction
Human serum albumin (HSA) is the most abundant protein
of blood serum, at a concentration of ca. 0.6mM (∼4%).
It is a versatile carrier protein, involved in the transport
of hormones, vitamins, fatty acids, xenobiotics, drugs and
metabolites [1]. HSA also carries metal ions, including
physiological Ca2+,Z n 2+,C o 2+,a n dC u 2+,a sw e l la st o x i c
Cd2+ and Ni2+ [1–3]. Four distinct metal binding sites have
been characterized so far in HSA. Cys-34, the only free thiol
in HSA, is located at the bottom of a hydrophobic pocket.
It selectively binds hydrophobic complexes of heavy metal
ions, such as Pt2+ and Au+ [4–7] .T h r e eo t h e rs i t e sa r em o r e
accessible and more versatile. The N-terminal binding site
(NTS, also called the ATCUN motif) has been characterized
particularly well. It is composed of the ﬁrst three amino acid
residues of the HSA sequence, Asp-Ala-His. This sequence is
not conﬁned sterically, as evidenced by the absence of trace
of these residues in X-ray structures of HSA [1, 2] and has
a conformational freedom to wrap around a metal ion. The
resulting square-planar complex exhibits a rare coordination
mode with deprotonated amide nitrogens of Ala and His
residues, in addition to the N-terminal amine and the His-
3 imidazole donor [8–10]. It provides the primary binding
site for Cu(II) and Ni(II) ions and the tertiary site for Co(II)
ions [10, 11]. We recently demonstrated that the conditional
dissociation constant for Cu(II) binding at the NTS is as
low as 1pM [12]. The studies of short peptide models of
similar His-3 sites performed in our and other laboratories,
for example, by Hadjiliadis et al., uniformly indicated their
very high aﬃnities for Cu(II), and also Ni(II) ions [13–15].
There is abundant experimental evidence for the complete
saturation of the coordination sphere of the Cu(II) ion
bonded to NTS and model peptides [9, 11–16].2 Bioinorganic Chemistry and Applications
Another site is composed of side chains of His67, His247,
Asn99 i Asp249. It is located at the interface of domains
I and II of HSA. We named it multimetal binding site
(MBS) in our previous study, because we demonstrated
that it can bind Cu(II), Ni(II), Zn(II), Cd(II), as well as
Co(II) ions with comparable aﬃnities [10, 11]. This site is
identical with cadmium site B (CdB) characterized by NMR
spectroscopy [17–19]. Recent studies on Zn(II) binding at
MBS provided crucial data about its spatial arrangement
[18]. The location of the third site, called cadmium site A
(CdA), remains unknown. It is the primary site for Cd(II)
and Co(II) ions but does not participate in Cu(II) binding
[11].
The structure of MBS was analyzed by NMR and
molecular modeling of the Zn(II) complex [18]. The Zn(II)
ion is pentacoordinate in a square pyramidal geometry, with
equatorialcoordinationprovidedbytwoimidazolenitrogens
(His67 and His247), a carboxylate oxygen (Asp249) and a
carbonyl oxygen (Asn99). The axial site in this structure
is occupied by a water molecule. This fact suggests that
the MBS binding site may be modiﬁed by external ligands,
forming hypothetical ternary species.
In this work we attempted to ﬁnd out whether com-
mon buﬀers may interact with the Cu(II) ion bonded at
MBS. We also tested whether occupation of hydrophobic
pockets, which are used for transportation of endogenous
and exogenous aromatic molecules [20–23], may aﬀect the
coordination properties of MBS.
2. Experimental
2.1. Materials. Homogeneous, high purity defatted HSA was
obtainedfromSigma.CuCl2,H epes,T ris,sodiumphosphate,
and NaCl were obtained from Aldrich. Stock solution of
CuCl2 was standardized complexometrically. CuCl2 solu-
tions were calibrated as described in [15]. NaOH and HCl
were purchased from Merck.
2.2. Methods. The CD spectra were recorded at 25
◦Co na
Jasco J-715 spectropolarimeter (JASCO, Japan Spectroscopic
Co., Hiroshima, Japan), over the range of 300–800nm, using
a 1cm cuvette. The spectra are expressed in terms of Δε =
εl − εr,w h e r eεl and εr are molar absorption coeﬃcients for
left and right circularly polarized light, respectively. In buﬀer
experiments the solutions contained 100mM Hepes, Tris,
Sodium Phosphate, or NaCl, at pH 7.4.
HSA was dissolved at 0.3–0.5mM in either a 100mM
Hepes, Tris, Sodium Phosphate buﬀers, pH 7.4, or in an
unbuﬀered 100mMNaCl solution. The pH of both types of
samples was controlled to remain in the 7.38–7.42 corridor
and adjusted with submicroliter amounts of concentrated
HCl or NaOH when necessary. Concentrations of stock
solutions of HSA were estimated spectrophotometrically
at 279nm [9] and by Cu(II) titrations. The fractional
abundance of NTS in HSA was measured by careful CD
titrations using calibrated Cu(II) solutions. The average
value of 0.73 was obtained, in agreement with the previous
studies [10–12, 15, 24].
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Figure 1: CD spectra of Cu(II) titration of HSA (0.5mM in
0.1MNaCl, pH 7.4), from 0 to 3mol equivalents, at a 0.25mol
equivalent step.
3. Results and Discussion
3.1. The Eﬀect of Buﬀers on the Binding of Cu(II) Ions at MBS.
We chose sodium phosphate, Tris and Hepes as the most
common substances used for buﬀering protein solutions at
pH 7.4. Their eﬀect on Cu(II) binding to HSA was studied
at a 0.1M concentration stage versus unbuﬀered 0.1MNaCl,
used as a control solution. The choice of the latter was
dictated by the presence of 0.1M chloride in the blood
serum [25]. The pH of the NaCl samples was controlled by
additions of small quantities of concentrated HCl or NaOH
solutions, when necessary. This was achieved thanks to the
self-buﬀering properties of HSA, based on the presence of
multiple His residues on its surface [9, 26]. The titrations
were monitored by CD spectroscopy, analogously to our
previous studies [10, 15].
A typical titration is presented on Figure 1. Figure 2
shows titration curves, obtained from titration experiments
by plotting the changes of ellipticity (Δθ)a tλmax of Cu(II)
complexes at MBS (665nm for Tris and 695nm for remain-
ing solutions). The changes of ellipticities of transitions
related to Cu(II) complexes at NTS, at 492 and 565nm, were
linear up to the NTS saturation, in accordance with a very
high aﬃnity of this site [12].
The pure spectra of NTS and MBS complexes in individ-
ual solutions, calculated by extrapolation of titration data,
are shown in Figures 3 and 4, respectively. The shapes and
intensities of NTS bands were not aﬀectedbybuﬀers studied.
In contrast, the presence of Tris altered the appearance of
the characteristic MBS band considerably, compared to the
NaCl reference. The eﬀects of phosphate and Hepes were less
pronounced, but still signiﬁcant.
Apparent binding constants (Kapp) for Cu(II)-MBS
complexes in the presence of buﬀers were obtained from
titrations presented in Figure 2. These constants, calculated
on a technical assumption of the formation of binary species
only, are presented in Table 1. Table 1 contains also further
constants, calculated relative to the Cu(II)-MBS interaction
in NaCl, taken as corresponding to a 100% binary complex
formation. These calculations were prompted by spectralBioinorganic Chemistry and Applications 3
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Figure 2: Titration curves (experimental points, , and ﬁts to the Kapp formula, ) for Cu(II) binding at MBS in four solutions studied:
(a) NaCl; (b) Hepes; (c) sodium phosphate; (d) Tris.
eﬀects described above and by signiﬁcant diﬀerences among
log Kapp values.
First, the eﬀects of competition of buﬀers for Cu(II) were
accounted for Literature protonation and Cu(II) binding
constants of Hepes [27], Tris [28], and phosphate ions [29]
were used in these calculations. The competition-only model
of interaction, could not, however, reproduce the titration
curves, and it was necessary to include ternary complex
formation. Figure 5 illustrates this issue for the case of Hepes
buﬀer. The shift of the MBS d → d band to higher energies
by30nm,from695on665nm,alsoprovidedanunequivocal
piece of evidence in favor of ternary complex formation
with Tris. Calculations based on this assumption, performed
for all three buﬀers, yielded equilibrium constants, given in
Table 1. The reactions deﬁning these constants are provided
in the footnotes of Table 1.
Brieﬂy, K111 describes the overall formation of a ternary
species, K11 is the literature binding constant of the Cu(II)
complex of a buﬀer, Ke corresponds to the ternary complex
formation by addition of buﬀer-complexed Cu(II) to MBS,
and KT is the equilibrium constant of the formation of the
ternary complex in the reaction of two binary complexes,
thus featuring the tendency of binary components to form
a ternary species [33]. All these constants, except for K11,a r e
conditional in respect to the pH value of 7.4.
Calculations of titrations in these buﬀers demonstrated
that the observed spectra were practically pure spectra of
mixed complexes. The participation of the binary MBS4 Bioinorganic Chemistry and Applications
Table 1: Quantitative description of ternary complexes formed by Cu(II) ions at MBS of HSA at pH 7.4. Standard deviations of signiﬁcant
values of experimental logarithms constants on the last digits are given in parentheses.
Ligand (L) log Kapp log K111
a log K11
b log Ke
c log KT
d CI
e
[L] = 0.5mM 100mM
NaCl 4.60(3) 7.62
Hepes 4.45(5) 7.54(5) 3.22 4.32 −0.28 7.71 9.27
Tris 4.23(6) 8.22(5) 4.05 4.17 −0.43 7.74 9.42
Phosphate 5.17(7) 8.2(1) 3.20 5.00 +0.40 8.04 10.13
a K111 is the equilibrium constant of the reaction Cu2+ +L+MBS= Cu(MBS)(L).
b K11 is the equilibrium constant of the reaction Cu2+ +L= Cu(L); literature values [30–32].
c Ke is the equilibrium constant of the reaction MBS + Cu(L) = Cu(MBS)(L); log K111 = log K11 +l o gKe.
dKT is the equilibrium constant of the reaction Cu(MBS) + Cu(L) = Cu(MBS)(L) + Cu2+.
log KT = log K111 −log K11 −log Kapp (NaCl).
eCI is the competitivity index (description in text), calculated for following total concentrations: Cu(II) and Z = 1μM, HSA = 0.5mM, buﬀer = 0.5mM, or
100mM.
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Figure 3: Spectra of pure forms of NTS-Cu(II) complexes obtained
by extrapolation of titration data.
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Figure 4:SpectraofpureformsofMBS-Cu(II)complexesobtained
by extrapolation of titration data.
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Figure 5: Comparison of experimental data () ,t h eb e s tﬁ tt ot h e
ternary complex model ( ), and the simulation of titration in the
absence of ternary complex formation ( ) for the titration of MBS
in 0.1M Hepes, pH 7.4.
complex was less than 1.5% at all titration points. This
feature allowed us to speculate about the binding modes in
ternary complexes. The spectra for Hepes and phosphate
were practically identical with those of the binary complex,
but the titration curves demonstrated the signiﬁcant quan-
titative deviation from the binary complex-only binding.
Therefore, the most likely binding mode for these two
substances is that based on a substitution of the axial water
molecule with a buﬀer oxygen donor. The comparatively
high binding constants for ternary complexes, in relation to
binary complexes, demonstrated the creation of accessorial
interactions between HSA and the ligand. The blueshift and
change of the band intensity for Tris suggests a substitution
of an equatorial oxygen, perhaps that of Asn99.
CI values presented in the last column of Table 1 were
calculated for total concentrations for Cu(II) and the formal
competitor Z = 1μMa n df o rH S A= 0.5mM at pH =
7.4. These calculations were done in two versions—for
L( b u ﬀer) concentrations of 0.5mM and 100mM. These
concentrations of HSA and Cu(II) ions corresponded toBioinorganic Chemistry and Applications 5
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Figure 6: Chemical structures of warfarin (War, left) and ibuprofen (Ibu, right).
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Figure 7: Titrations of HSA in the presence of 1.75mol equivalents
of Cu(II) with War (A) and Ibu (B) from 0 to 2.5mol equivalents
in 0.25mol equivalent steps. The titration of War was terminated at
2mol equivalents due to the loss of solution transparency. The solid
lines represent linear ﬁts to the data.
physiological values, the latter to the exchangeable pool of
Cu(II) in blood plasma [32]. From these calculations, one
can infer that the formation of ternary complexes with
buﬀers had a relatively small impact on the aﬃnity of Cu(II)
ions to MBS. The values of KT demonstrated that Hepes
and Tris buﬀers somewhat destabilized this interaction, and
phosphate ion showed a stabilizing eﬀect. However, their
eﬀects on Cu(II) binding were signiﬁcant at practically
used buﬀer concentrations of 100mM. Hepes was applied
in successive investigations, because this buﬀer showed the
smallest interference with Cu(II) binding parameters of
MBS.
3.2. Interaction between MBS and Hydrophobic Pockets for
Aromatic Molecules. It was interesting to ﬁnd out whether
the binding of warfarin (War) and ibuprofen (Ibu) Figure 6,
exogenous ligands characteristic for hydrophobic pockets
(Sudlow’s sites) I and II in HSA, respectively, could inﬂuence
Cu(II) binding at NTS, and, in particular MBS.
In these experiments we used HSA samples containing
1.75mol equivalents of Cu(II) ions. According to the results
and discussion presented above, these samples contained
fully saturated NTS and one mole equivalent of Cu(II) in an
equilibriumwithMBS,atabout80%saturation.Thesamples
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Figure 8:ComparisonoftitrationcurvesforCu(II)bindingatMBS
obtained in the presence of 1mol equivalents of Ibu (experimental
points, , and ﬁts to the Kapp formula, ) and War (experimental
points, , and ﬁts to the Kapp formula, ).
were titrated separately with War and Ibu. None of these
two substances possesses donor groups, which would can
eﬀectively bind Cu(II) ions in solution. This notion was
conﬁrmed by the absence of complex formation ﬁngerprints
in UV-vis spectroscopy and circular dichroism (CD) spectra
(data not shown), and by the literature [20–22, 34, 35].
The HSA binding constants for War (3.3 ×105 M−1)a n d
Ibu(2.7×106 M−1)[30,36–38]ar es uﬃcientlyhigh to assure
stoichiometric binding to their respective binding pockets in
0.5mM HSA solutions—the addition of one equivalent of
ligand yields a 93% saturation for War and a 99% saturation
for Ibu. Figure 7 shows the titrations of 0.5mM HSA with
WarandIbuinthepresenceof1.75molequivalentsofCu(II)
ions. In the course of these titrations, we observed a speciﬁc
decrease of intensity of the MBS band. The band position
remained unchanged. The eﬀect of Ibu was very subtle,
but that of War was clearly pronounced. Interestingly, the
linearityofthebandintensitydecreasewassimilarbeforeand
after the stoichiometric binding point for both HSA ligands.
Figure 8 presents titrations of HSA with Cu(II) ions in
the presence of stoichiometric (1mol equivalent) amounts
of War and Ibu, performed in a 100mM Hepes buﬀer, pH
7.4. The Ibu titration yielded the log Kapp value of 4.49(5),
identical within the experimental error with that obtained in6 Bioinorganic Chemistry and Applications
100mM Hepes in the absence of Ibu (4.45(5), Table 1). The
presence of War had however a pronounced eﬀect on Cu(II)
binding. A very low log Kapp value of 3.2(2) was obtained.
Therefore, the binding of War decreased the aﬃnity of MBS
for Cu(II) by a factor of 20. The Cu(II) binding at NTS was
unaﬀected in both cases.
The eﬀects presented in Figures 7 and 8 can be inter-
preted by taking into account the locations of hydrophobic
pockets. War binds speciﬁcally at site I, which is located in
subdomain IIA of HSA, while Ibu binds speciﬁcally at site II,
which is located in subdomain IIIA [1, 2, 31]. MBS is located
at the interface of domains IB and IIA, much closer to site I
than to site II, which is separated from MBS by a very large
crevice [32]. Based on the present data, we can speculate that
the binding of warfarin induced a conformational change
which decreased the accessibility of MBS. The absence of
CD spectral changes of the Cu(II)-MBS complex indicated,
however, that the geometry of the site itself was not aﬀected.
4. Conclusion
The results presented above clearly indicate that the Cu(II)
binding properties of MBS of HSA can be inﬂuenced by
external ligands. The order of buﬀer aﬃnities for the forma-
tion of ternary MBS-Cu(II)-Buﬀer complexes, phosphate >
Hepes > Tris, indicates that the interaction is not limited
to the binding with the metal ion. This notion is supported
by strong spectral changes induced speciﬁcally by Tris, which
clearly indicate the addition of the Tris nitrogen atom to the
coordination sphere of MBS-bound Cu(II) ion. The indirect
eﬀect of warfarin indicates a speciﬁc negative control of MBS
binding of metal ions by site I ligands.
MBS is unlikely to carry Cu(II) physiologically but is
considered as a major transport site for Zn(II) ions in blood
plasma[18].Theinteractionsdescribedinthispaperarevery
likely to be shared by MBS occupied by a Zn(II) ion, because
Cu(II) and Zn(II) binding modes are thought to be very
similar. Therefore, Zn(II) binding properties of MBS may be
modulated directly and indirectly by small molecules. This
physiologically important issue will be investigated in our
future studies.
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